Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General visceral afferent fibers are sensory nerve fibers of the peripheral nervous system that transmit sensory information, such as pain or physiological stimuli, from the internal organs (viscera), glands, and blood vessels to the central nervous system[1][3][5][6]. Their cell bodies are located in dorsal root and some cranial ganglia. GVA fibers are critical for reflex regulation of visceral function (e.g., heart rate, gut motility) and for transmitting visceral pain, often resulting in referred pain phenomena[1][3][5][8]. These fibers are not a molecular target (e.g., receptor or enzyme) but instead a complex anatomical and functional category encompassing many distinct fiber types and expressing diverse populations of neurotransmitters and receptors depending on organ, function, and anatomical pathway[2][4][6]. They are not a single molecular entity and thus are not considered conventional molecular therapeutic targets. Instead, they are a complex population of sensory nerve fibers involved in bodily sensory and autonomic feedback. Explanation: - is_incorrect: true, because "Visceral afferent fibers" are not a single molecule, receptor, or well-defined therapeutic target, but a heterogeneous population of sensory nerve fibers[1][3][4][6]. - interacting_drugs, mechanism_of_action, biomarkers, safety_concerns: null, because drugs do not directly "target" GVA fibers as a molecular entity, although some drugs (e.g., lidocaine, capsaicin, opioids) may modulate their activity as a population—but these do not selectively or specifically target "visceral afferent fibers" as a canonical molecular target. If a molecular target (such as a receptor subtype predominantly expressed by a subclass of visceral afferents, e.g., TRPV1, P2X3, or Nav1.7 sodium channels) is requested, this would need further specification[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General visceral afferent fiber (GVA fiber).